Interleukin-33 and Lower Tract Respiratory Diseases: Moving From Pathophysiology to Management скачать в хорошем качестве

Interleukin-33 and Lower Tract Respiratory Diseases: Moving From Pathophysiology to Management

This live dinner symposium features expert panelists Dr. Jonathan M. Hand, Professor Dave Singh, and Professor Tom Wilkinson, who will explore the role of IL-33 in lower respiratory tract diseases and offer their insights on the latest advancements in treatment strategies that target its mechanisms. Agenda topics to be covered include the dual biologic function of IL-33 as both an inflammatory mediator and regulator of gene expression, IL-33 signaling pathways, implications of its dysregulation on the pathology of respiratory disease, rationale for targeting IL-33 for treatment development, and ongoing clinical investigations of biologic agents that inhibit IL-33. Interactive discussions and Q&A session will provide further opportunities for participant engagement and learning. Join us for this live and informative program! Participate in the CME Live Stream https://exchangecme.com/IL33SanFranci... #ATS2025 #ats #respiratorydiseases Jonathan M. Hand, MD Associate Professor of Internal Medicine The University of Queensland Medical School - Ochsner Health New Orleans, Louisiana Professor Dave Singh MD, FERS, FBPhS Professor of Clinical Pharmacology and Respiratory Medicine, University of Manchester Medical Director, Medicines Evaluation Unit. Honorary Respiratory Consultant, Manchester University Foundation Hospitals Trust London, United Kingdom Professor Tom Wilkinson MA Cantab MBBS PhD FRCP FERS Professor of Respiratory Medicine Associate Dean Faculty of Medicine Honorary Consultant UHS NHS FT NIHR Senior Investigator National Respiratory Audit Programme (NRAP) Senior Clinical Lead University of Southampton Southampton, United Kingdom